title: Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
abstract: OBJECTIVE
  Endometriosis is a disorder in which the endometrium forms growths outside the uterus and is associated with chronic pain. Recent evidence suggests that endometrial motility plays a role in the aetiology of endometriosis. The endocannabinoid system regulates cellular migration. Given the growing involvement of the endocannabinoids in reproduction, we investigated the role of the endocannabinoid system in migration of endometrial cells.
  
  
  METHODS
  Migration of the human endometrial HEC-1B cells was assayed. Standard PCR techniques were used to determine the presence of the GPCR, GPR18, in HEC-1B cells, and p44/42 MAPK was assayed in stably transfected HEK293-GPR18 cells to determine receptor specificity for known cannabinoid agonists and antagonists. N-arachidonoyl ethanolamine (AEA) metabolism was measured, using HPLC/MS/MS for lipid analysis.
  
  
  RESULTS
  AEA, Δ(9) -tetrahydrocannabinol (Δ(9) -THC) and N-arachidonoyl glycine (NAGly) induce migration of HEC-1B cells through cannabinoid CB(1) receptor-independent mechanisms. MAPK activation in HEK293-GPR18 cells revealed novel pharmacology for known CB(1) and CB(2) receptor ligands at GPR18 receptors, including Δ(9) -THC, which activates MAPK at nanomolar concentrations, whereas WIN 55212-2, CP55940, JWH-133 and JWH-015, and arachidonyl-1-hydroxy-2-propylamide (R1-methanandamide) had no effect. Moreover, HEC-1B migration and MAPK activation by NAGly and Δ(9) -THC were antagonized by Pertussis toxin, AM251 and cannabidiol.
  
  
  CONCLUSIONS
  An understanding of the function and regulation of GPR18 and its molecular interactions with endogenous ligands, and how phytocannabinoids play a role with GPR18 signalling is vital if we are to comprehensively assess the function of the cannabinoid signalling system in human health and disease.
  
  
  BACKGROUND
  This article is commented on by Alexander, pp. 2411-2413 of this issue and is part of a themed section on Cannabinoids in Biology and Medicine. To view Alexander visit http://dx.doi.org/10.1111/j.1476-5381.2011.01731.x. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue-7.
authors: Department of Psychological and Brain Sciences, Indiana University, Bloomington,IN 47405, USA.
authors: Douglas
authors: D
authors: McHugh
authors: Jeremy
authors: J
authors: Page
authors: Emily
authors: E
authors: Dunn
authors: Heather B
authors: HB
authors: Bradshaw
references: BMC Neurosci. 2010 Mar 26;11:44
references: 20346144
references: Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S3-11
references: 18294762
references: Tumour Biol. 1996;17(1):48-57
references: 7501972
references: J Neurochem. 1997 Jan;68(1):402-9
references: 8978752
references: Histochem Cell Biol. 2010 May;133(5):557-65
references: 20369362
references: J Biol Chem. 2001 Nov 16;276(46):42639-44
references: 11518719
references: J Med Chem. 1994 Jun 10;37(12):1889-93
references: 8021930
references: J Pharmacol Exp Ther. 2000 Jul;294(1):204-9
references: 10871313
references: J Med Chem. 1999 Feb 25;42(4):769-76
references: 10052983
references: J Assist Reprod Genet. 2010 Aug;27(8):441-7
references: 20574791
references: J Neurosci. 2003 Feb 15;23(4):1398-405
references: 12598628
references: Mol Hum Reprod. 2002 Feb;8(2):188-95
references: 11818522
references: Br J Pharmacol. 2003 Aug;139(8):1417-24
references: 12922928
references: Br J Pharmacol. 2011 Nov;164 Suppl 1:S1-324
references: 22040146
references: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
references: 10570211
references: Neurosci Lett. 1997 May 30;228(1):29-32
references: 9197280
references: Pharmacol Ther. 2005 May;106(2):133-45
references: 15866316
references: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4188-92
references: 9108127
references: Endocrinology. 2006 Mar;147(3):1097-121
references: 16306079
references: J Med Chem. 1997 Feb 28;40(5):659-67
references: 9057852
references: J Biol Chem. 2000 May 26;275(21):15621-8
references: 10821843
references: AAPS J. 2006 Apr 28;8(2):E298-306
references: 16796380
references: Science. 1992 Dec 18;258(5090):1946-9
references: 1470919
references: Biochem Biophys Res Commun. 2006 Sep 1;347(3):827-32
references: 16844083
references: J Biol Chem. 2003 Nov 14;278(46):46188-94
references: 12952947
references: J Exp Clin Assist Reprod. 2006 Mar 30;3:3
references: 16573810
references: Br J Pharmacol. 2007 Nov;152(5):567-75
references: 17906678
references: Endocrinology. 2006 Mar;147(3):1203-12
references: 16339197
references: Mol Hum Reprod. 2002 Jul;8(7):651-8
references: 12087080
references: J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):149-55
references: 12650711
references: BMC Biochem. 2009 May 21;10:14
references: 19460156
references: Prostaglandins Other Lipid Mediat. 2000 Apr;61(1-2):29-41
references: 10785540
references: Fertil Steril. 2010 May 15;93(8):2588-93
references: 20303477
references: Eur J Biochem. 2000 May;267(10):2991-7
references: 10806398
references: Hypertension. 1999 Jan;33(1 Pt 2):429-34
references: 9931142
references: Pharmacol Rev. 2010 Dec;62(4):588-631
references: 21079038
references: Hypertension. 2002 Feb;39(2):251-7
references: 11847193
references: Mol Pharmacol. 2001 Jan;59(1):9-15
references: 11125018